Showing 7081-7090 of 10619 results for "".
- Universal Age-Based Lung Cancer Screening: Expanding Horizonshttps://reachmd.com/news/universal-age-based-lung-cancer-screening-expanding-horizons/2484548/Most lung cancers remain undetected at an early stage. A systems-level shift to
- Addressing Postoperative Geriatric Syndromes: Strategies and Outcomes for Older Adultshttps://reachmd.com/news/addressing-postoperative-geriatric-syndromes-strategies-and-outcomes-for-older-adults/2484567/A Medicare claims analysis shows that older surgical patients who develop new postoperat
- Enhancing Global AMR Strategies: Balancing Equity and Data-Driven Decisionshttps://reachmd.com/news/enhancing-global-amr-strategies-balancing-equity-and-data-driven-decisions/2484573/A recent call urges an updated Global Action Plan that expands pathogen coverage to parasitic and viral agents, centers equity, and builds interoperable data systems, addressing a clinical landscape now marked by increasingly complex resistant organisms that complicate surveillance
- Emerging Influenza Threat: New Variant Challenges U.S. Seasonal Preparednesshttps://reachmd.com/news/emerging-influenza-threat-new-variant-challenges-us-seasonal-preparedness/2484553/The influenza subclade K variant is spreading internationally and could presage a more severe U.S. influenza season. Rising counts in multiple high-surveillance countries, coup
- Maternal Health Crisis: Addressing the Stagnation and Inequities in the U.S.https://reachmd.com/news/maternal-health-crisis-addressing-the-stagnation-and-inequities-in-the-us/2484542/The March of Dimes report finds U.S. maternal health has stalled: persistent preterm birth and widening inequities demand system-level responses.
- Emerging Promise of Preoperative Radiation in Hormone-Positive Breast Cancerhttps://reachmd.com/news/emerging-promise-of-preoperative-radiation-in-hormone-positive-breast-cancer/2484502/A study led by researchers at UT Southwestern Medical Center found that single-dose preoperative radiation produced a high rate of pathologic complete responses in an
- Assessing the Impact of Ablation Plus Immunotherapy in Advanced NSCLC: Insights from the BOOSTER Phase 2 Trialhttps://reachmd.com/news/assessing-the-impact-of-ablation-plus-immunotherapy-in-advanced-nsclc-insights-from-the-booster-phase-2-trial/2484459/In the BOOSTER trial, adding local tumor ablation to ongoing anti-PD-1/L1 therapy markedly extended progression-free survival in advanced NSCLC with oligo-residual disease. The randomized phase 2 trial demonstrates an immediately actionable approach to prolong diseas
- Tralokinumab Maintains Efficacy in Hand AD Through 32 Weekshttps://reachmd.com/news/tralokinumab-maintains-efficacy-in-hand-ad-through-32-weeks/2484484/LEO Pharma has announced positive 32-week topline results from its ADHAND trial, a phase 3b study evaluating tralokinumab in adults with moderate-to-severe atopic dermatitis (AD) with hand involvement. According to a press rele
- EBV's Role in Lupus Pathogenesis: Insights from Stanford Researchhttps://reachmd.com/news/ebvs-role-in-lupus-pathogenesis-insights-from-stanford-research/2484465/A Stanford-led study demonstrates that Epstein-Barr virus (EBV) infection reprograms B cells into a defined driver phenoty
- Clinical Impact of Icotrokinra in Plaque Psoriasis Across Age Groupshttps://reachmd.com/news/clinical-impact-of-icotrokinra-in-plaque-psoriasis-across-age-groups/2484461/Icotrokinra produced rapid, clinically meaningful skin clearance in adults and adolescents with moderate-to-severe plaque psoriasis, offering a new systemic option for patients who need a quick, high-level response. In a phase 3 study with a week‑16 primary endpoint,